SIGVOTATUG
UNII ZD7KM155DD

Substance Identification & Data

This profile provides standardized clinical and technical data for Sigvotatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZD7KM155DD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2764774-90-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZD7KM155DD

CAS Registry Number

2764774-90-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIGVOTATUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203046

National Cancer Institute reference terminology for clinical and research data.

INN ID

12758

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-201

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sigvotatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIGVOTATUG

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV1-46*01 (79.6%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT(8.8.9) (26-33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01,G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357)(340-444), CHS (445-446)) (117-446)), (219-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (83.2%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (153'), V101 (191') (108'-214')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS

H2A2

SIGVOTATUG [INN]

SIGVOTATUG [USAN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .BETA.6) (HUMAN-MUS MUSCULUS MONOCLONAL H2A2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL H2A2 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ITGB6 (INTEGRIN SUBUNIT BETA 6)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV1-46*01 (79.6%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.8.9) (26-33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)), (219-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (83.2%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (153'), V101 (191') (108'-214')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

SYS

External Clinical & Regulatory Resources

Previous UNIIZD7F9G5T6R

Next UNIIZD832NK3DC